Quiros Roldan E - Search Results

1

Haemostatic activation in HIV infected patients treated with different antiretroviral regimens.

Pan A, Testa S, Quiros Roldan E, Tinelli C, Bodini U, Cadeo B, Carnevale G, Martinelli I, Maserati R, Morstabilini P, Seminari E, Signorini L, Carosi G. Pan A, et al. Among authors: quiros roldan e. Curr HIV Res. 2008 Jan;6(1):70-6. doi: 10.2174/157016208783571928. Curr HIV Res. 2008. PMID: 18288978

2

HIV-1 pharmacoresistance: clinical and therapeutic implications.

Carosi G, Torti C, Palvarini L, Quiros Roldan E. Carosi G, et al. Among authors: quiros roldan e. J Biol Regul Homeost Agents. 1999 Jul-Sep;13(3):163-71. J Biol Regul Homeost Agents. 1999. PMID: 10560750 Review.

3

Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment.

Puoti M, Gargiulo F, Quiros Roldan E, Chiodera A, Palvarini L, Spinetti A, Zaltron S, Putzolu V, Zanini B, Favilli F, Turano A, Carosi G. Puoti M, et al. Among authors: quiros roldan e. J Infect Dis. 2000 Jun;181(6):2033-6. doi: 10.1086/315529. Epub 2000 May 31. J Infect Dis. 2000. PMID: 10837187

4

Mortality for liver disease in patients with HIV infection: a cohort study.

Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, Quiros-Roldan E, Zanini B, Casari S, Carosi G. Puoti M, et al. Among authors: quiros roldan e. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):211-7. doi: 10.1097/00126334-200007010-00003. J Acquir Immune Defic Syndr. 2000. PMID: 10969344

5

Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.

Quiros-Roldan E, Signorini S, Castelli F, Torti C, Patroni A, Airoldi M, Carosi G. Quiros-Roldan E, et al. J Clin Lab Anal. 2001;15(1):43-6. doi: 10.1002/1098-2825(2001)15:1<43::aid-jcla9>3.0.co;2-i. J Clin Lab Anal. 2001. PMID: 11170234 Free PMC article.

6

Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients.

Quiros-Roldan E, Moretti F, Airoldi M, Fausti C, Chiodera A, Castelli F, Carosi G. Quiros-Roldan E, et al. J Clin Lab Anal. 2001;15(3):127-30. doi: 10.1002/jcla.1015. J Clin Lab Anal. 2001. PMID: 11344527 Free PMC article.

7

HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatment.

Quiros-Roldan E, Bertelli D, Signorini S, Airoldi M, Torti C, Moretti F, Carosi G. Quiros-Roldan E, et al. Microbios. 2001;106(414):137-45. Microbios. 2001. PMID: 11506064

8

Evidence of HIV-2 infection in northern Italy.

Quiros-Roldan E, Castelli F, Pan A, Chiodera S, Casari S, Airoldi M, Carosi G. Quiros-Roldan E, et al. Infection. 2001 Dec;29(6):362-3. doi: 10.1007/s15010-001-2025-6. Infection. 2001. PMID: 11787844 No abstract available.

9

[New strategies and new drugs in the salvage therapy for HIV infection].

Quirós-Roldán E, Torti C, Pan A, Carosi G. Quirós-Roldán E, et al. Med Clin (Barc). 2002 Feb 23;118(6):222-4. doi: 10.1016/s0025-7753(02)72341-5. Med Clin (Barc). 2002. PMID: 11864546 Review. Spanish. No abstract available.

10

Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy.

Torti C, Patroni A, Tinelli C, Sleiman I, Quiros-Roldan E, Puoti M, Castelli F. Torti C, et al. Among authors: quiros roldan e. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):315-7. doi: 10.1097/00126334-200203010-00015. J Acquir Immune Defic Syndr. 2002. PMID: 11873084 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters